Landec Corporation  

(Public, NASDAQ:LNDC)   Watch this stock  
Find more results for LNDC
+0.17 (1.37%)
Nov 25 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 12.37 - 12.66
52 week 11.02 - 15.16
Open 12.37
Vol / Avg. 153,316.00/51,221.00
Mkt cap 334.72M
P/E 24.31
Div/yield     -
EPS 0.52
Shares 27.02M
Beta 1.20
Inst. own 92%
Jan 4, 2016
Q2 2016 Landec Corp Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Dec 9, 2015
Landec Corp at Wedbush Securities California Dreamin' Technology Consumer Management Access Conference Add to calendar
Nov 18, 2015
Landec Corp at Three Part Advisors Southwest IDEAS Investor Conference
Oct 15, 2015
Landec Corp Annual Shareholders Meeting
Oct 9, 2015
Landec Corp Annual Shareholders Meeting (Estimated)
Sep 30, 2015
Q1 2016 Landec Corp Earnings Call - Webcast
Sep 29, 2015
Q1 2016 Landec Corp Earnings Release
Sep 17, 2015
Landec Corp at Imperial Capital Global Opportunities Conference
Sep 16, 2015
Landec Corp at B. Riley & Co Retail & Consumer Conference
Sep 9, 2015
Landec Corp at Liolios Group Gateway Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Aug '15) 2015
Net profit margin 2.21% 2.55%
Operating margin 2.91% 3.42%
EBITD margin - 4.74%
Return on average assets 3.48% 4.16%
Return on average equity 5.37% 6.43%
Employees 550 -
CDP Score - -


3603 Haven Avenue
United States - Map
+1-650-3061650 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Landec Corporation designs, develops, manufactures and sells differentiated products for food and biomaterials markets and licenses technology applications to partners. The Company's segments include Food Products Technology, Food Export and Hyaluronan-based Biomaterials. The Company's Food Products Technology segment markets and packs specialty packaged whole and fresh-cut fruit and vegetables. The Company's Food Export segment is engaged in the purchase and sale of whole commodity fruit and vegetable products to Asia and domestically. The Company's Hyaluronan-based Biomaterials segment sells products utilizing hyaluronan, a polysaccharide that is distributed in the extracellular matrix of connective tissues in both animals and humans, for medical use primarily in the ophthalmic, orthopedic and veterinary markets. The Company licenses its Intellicoat seed coatings to the farming industry and licenses its Intelimer polymers for personal care products and other industrial products.

Officers and directors

Gregory S. Skinner Chief Financial Officer, Vice President - Finance and Administration
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Nicholas Tompkins Chairman of the Board of Apio, Inc., Director
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Molly A. Hemmeter President, Chief Executive Officer
Age: 48
Bio & Compensation  - Reuters
Steven P. Bitler Ph.D. Vice President - Corporate Technology
Age: 57
Bio & Compensation  - Reuters
Larry D. Hiebert Vice President, President of Lifecore Biomedical, Inc.
Age: 59
Bio & Compensation  - Reuters
Ronald Lane Midyett Chief Operating Officer
Age: 49
Bio & Compensation  - Reuters
Steven D. Goldby Chairman of the Board
Age: 75
Bio & Compensation  - Reuters
Gary T. Steele Director
Age: 66
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Albert D. Bolles Ph.D. Independent Director
Age: 58
Bio & Compensation  - Reuters
Frederick Frank Independent Director
Age: 83
Bio & Compensation  - Reuters